Taiwanese Dermatological Association consensus statement on management of psoriasis

被引:31
作者
Tsai, Tsen-Fang [1 ,2 ]
Lee, Chih-Hung [3 ]
Huang, Yu-Huei [4 ,5 ]
Chi, Ching-Chi [5 ,6 ]
Chang, Yun-Ting [7 ]
Wong, Tak-Wah [8 ,9 ]
Yang, Chih-Hsun [4 ,5 ]
Wang, Li-Fang [1 ,2 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Dermatol, 7 Chung Shan South Rd, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, 7 Chung Shan South Rd, Taipei 100, Taiwan
[3] Kaohsiung Chang Gung Mem Hosp, Dept Dermatol, Kaohsiung, Taiwan
[4] Chang Gung Mem Hosp, Dept Dermatol, Number 5,Fusing St, Taoyuan, Taiwan
[5] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[6] Chang Gung Mem Hosp, Dept Dermatol, Chiayi, Chiayi, Taiwan
[7] Vet Gen Hosp Taipei, Dept Dermatol, Taipei, Taiwan
[8] Natl Cheng Kung Univ Hosp, Dept Dermatol, Tainan, Taiwan
[9] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan
关键词
consensus development; medication therapy management; psoriasis; Taiwanese Dermatological Association; TO-SEVERE PSORIASIS; CHRONIC PLAQUE PSORIASIS; INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; BAND UVB PHOTOTHERAPY; LOW-DOSE CYCLOSPORINE; LONG-TERM EFFICACY; DOUBLE-BLIND; COMBINATION THERAPY; 2-COMPOUND PRODUCT; CLINICAL-RESPONSE;
D O I
10.1016/j.dsi.2017.01.002
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Effective management of psoriasis is a cause for much concern. In Taiwan, there is a lack of consensus on management strategies for psoriasis, especially the principles of drug prescribing in psoriatic patients. Objectives: The Taiwanese Dermatological Association convened Expert Panel meetings three times between 2012 and 2015 to discuss the management strategies for treatment of psoriasis in order to fill the knowledge gap and provide a reference tool for Taiwanese dermatologists. Results: This paper reports the final output from the three meetings, with the aim of aiding clinical decision making in terms of principles of prescribing, including dosing strategies, efficacy profiles, and safety concerns in connection with eight categories of antipsoriatic treatment: topical agents, phototherapy, nonbiologic conventional systemic agents, licensed biologic systemic agents, newly emerging therapies, combination therapy, transitional therapy, and traditional Chinese medicine. Conclusion: The Expert Panel, comprising distinguished Taiwanese dermatologists, succeeded in developing a consensus about the management of psoriasis in Taiwanese patients. Unavailability of data in certain areas may suggest a possibility of new directions in research. Copyright (C) 2017, Taiwanese Dermatological Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
引用
收藏
页码:66 / 77
页数:12
相关论文
共 111 条
  • [1] Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?
    Aithal, GP
    Haugk, B
    Das, S
    Card, T
    Burt, AD
    Record, CO
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (04) : 391 - 399
  • [2] The use of cyclosporine in dermatology: Part I
    Amor, Karrie T.
    Ryan, Caitriona
    Menter, Alan
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (06) : 925 - 946
  • [3] Amor KT, 2010, J AM ACAD DERMATOL, V63, P47
  • [4] Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: A randomized, placebo-controlled study
    Asawanonda, Pravit
    Nateetongrungsak, Yaowalak
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (06) : 1013 - 1018
  • [5] Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation
    Bae, Yoon-Soo Cindy
    Van Voorhees, Abby S.
    Hsu, Sylvia
    Korman, Neil J.
    Lebwohl, Mark G.
    Young, Melody
    Bebo, Bruce, Jr.
    Kimball, Alexa Boer
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (03) : 459 - 477
  • [6] Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial
    Bissonnette, R.
    Iversen, L.
    Sofen, H.
    Griffiths, C. E. M.
    Foley, P.
    Romiti, R.
    Bachinsky, M.
    Rottinghaus, S. T.
    Tan, H.
    Proulx, J.
    Valdez, H.
    Gupta, P.
    Mallbris, L.
    Wolk, R.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (05) : 1395 - 1406
  • [7] COMBINATION OF ETRETINATE WITH CYCLOSPORINE IN THE TREATMENT OF SEVERE RECALCITRANT PSORIASIS
    BRECHTEL, B
    WELLENREUTHER, U
    TOPPE, E
    CZARNETZKI, BM
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 30 (06) : 1023 - 1024
  • [8] Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
    Burmester, Gerd R.
    Panaccione, Remo
    Gordon, Kenneth B.
    McIlraith, Melissa J.
    Lacerda, Ana P. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (04) : 517 - 524
  • [9] Cassell SE, 2007, J RHEUMATOL, V34, P123
  • [10] A study of candidate genes for psoriasis near HLA-C in Chinese patients with psoriasis
    Chang, YT
    Tsai, SF
    Lee, DD
    Shiao, YM
    Huang, CY
    Liu, HN
    Wang, WJ
    Wong, CK
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (03) : 418 - 423